Hai-Chen Pi1, Ye-Ping Ren2, Qin Wang2, Rong Xu1, Jie Dong3. 1. Renal Division, Department of Medicine, Institute of Nephrology, Peking University, Beijing, China. 2. Department of Nephrology, Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China. 3. Renal Division, Department of Medicine, Institute of Nephrology, Peking University, Beijing, China dongjie@medmail.com.cn.
Abstract
UNLABELLED: ♦ BACKGROUND: As an immune system regulator, vitamin D is commonly deficient among patients on peritoneal dialysis (PD), which may contribute to their impaired immune function and increased risk for PD-related peritonitis. In this study, we aimed to investigate whether vitamin D deficiency could predict the risk of peritonitis in a prospective cohort of patients on PD. ♦ METHODS: We collected 346 prevalent and incident PD patients from 2 hospitals. Baseline demographic data and clinical characteristics were recorded. Serum 25-hydroxyvitamin D (25[OH]D) was measured at baseline and prior to peritonitis. The mean doses of oral active vitamin D used during the study period were also recorded. The outcome was the occurrence of peritonitis. ♦ RESULTS: The mean age of patients and duration of PD were 58.95 ± 13.67 years and 28.45 (15.04 - 53.37) months, respectively. Baseline 25(OH)D level was 16.15 (12.13 - 21.16) nmol/L, which was closely associated with diabetic status, longer PD duration, malnutrition, and inflammation. Baseline serum 25(OH)D predicted the occurrence of peritonitis independently of active vitamin D supplementation with a hazard ratio (HR) of 0.94 (95% confidence interval [CI] 0.90 - 0.98) after adjusting for recognized confounders (age, gender, dialysis duration, diabetes, albumin, residual renal function, and history of peritonitis). Compared to the low tertile, middle and high 25(OH)D level tertiles were associated with a decreased risk for peritonitis with HRs of 0.54 (95% CI 0.31 - 0.94) and 0.39 (95% CI 0.20 - 0.75), respectively. ♦ CONCLUSIONS: Vitamin D deficiency evaluated by serum 25(OH)D rather than active vitamin D supplementation is closely associated with a higher risk of peritonitis.
UNLABELLED: ♦ BACKGROUND: As an immune system regulator, vitamin D is commonly deficient among patients on peritoneal dialysis (PD), which may contribute to their impaired immune function and increased risk for PD-related peritonitis. In this study, we aimed to investigate whether vitamin D deficiency could predict the risk of peritonitis in a prospective cohort of patients on PD. ♦ METHODS: We collected 346 prevalent and incident PDpatients from 2 hospitals. Baseline demographic data and clinical characteristics were recorded. Serum 25-hydroxyvitamin D (25[OH]D) was measured at baseline and prior to peritonitis. The mean doses of oral active vitamin D used during the study period were also recorded. The outcome was the occurrence of peritonitis. ♦ RESULTS: The mean age of patients and duration of PD were 58.95 ± 13.67 years and 28.45 (15.04 - 53.37) months, respectively. Baseline 25(OH)D level was 16.15 (12.13 - 21.16) nmol/L, which was closely associated with diabetic status, longer PD duration, malnutrition, and inflammation. Baseline serum 25(OH)D predicted the occurrence of peritonitis independently of active vitamin D supplementation with a hazard ratio (HR) of 0.94 (95% confidence interval [CI] 0.90 - 0.98) after adjusting for recognized confounders (age, gender, dialysis duration, diabetes, albumin, residual renal function, and history of peritonitis). Compared to the low tertile, middle and high 25(OH)D level tertiles were associated with a decreased risk for peritonitis with HRs of 0.54 (95% CI 0.31 - 0.94) and 0.39 (95% CI 0.20 - 0.75), respectively. ♦ CONCLUSIONS:Vitamin D deficiency evaluated by serum 25(OH)D rather than active vitamin D supplementation is closely associated with a higher risk of peritonitis.
Authors: Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk Journal: Perit Dial Int Date: 2010 Jul-Aug Impact factor: 1.756
Authors: H Taskapan; F F Ersoy; P S Passadakis; P Tam; D E Memmos; K P Katopodis; C Ozener; F Akcicek; T Camsari; K Ates; R Ataman; J G Vlachojannis; N A Dombros; C Utas; T Akpolat; S Bozfakioglu; G Wu; I Karayaylali; T Arinsoy; C P Stathakis; M Yavuz; D J Tsakiris; A D Dimitriades; M E Yilmaz; M Gültekin; D G Oreopoulos Journal: Clin Nephrol Date: 2006-10 Impact factor: 0.975
Authors: F Granado-Lorencio; I Blanco-Navarro; B Pérez-Sacristán; I Millán; E Donoso-Navarro; R A Silvestre-Mardomingo Journal: Eur J Clin Nutr Date: 2013-10-16 Impact factor: 4.016
Authors: Kevin A Sterling; Parham Eftekhari; Matthias Girndt; Paul L Kimmel; Dominic S Raj Journal: Nat Rev Nephrol Date: 2012-05-22 Impact factor: 28.314
Authors: Laura A G Armas; Radha Andukuri; Janet Barger-Lux; Robert P Heaney; Richard Lund Journal: Clin J Am Soc Nephrol Date: 2012-07-12 Impact factor: 8.237